Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 17/20 | 0.44 |
| ▸ | PPARA | Q07869 | 8/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4441891 | 0.82 | NR1H4 (0.45) | PPARDPPARANR1H4ALDH1A1SMN1; SMN2 | |
| SCHEMBL2528903 | 0.71 | PPARD (0.51) | PPARDPPARA | |
| SCHEMBL5657427 | 0.70 | NPC1 (0.55) | PPARDPPARAALDH1A1NPC1GAA | |
| SCHEMBL2528901 | 0.70 | PPARD (0.60) | PPARDPPARA | |
| SCHEMBL27650489 | 0.69 | NPC1 (0.56) | PPARDPPARANR1H4ALDH1A1NPC1 | |
| SCHEMBL2521255 | 0.69 | PPARA (0.59) | PPARDPPARAALDH1A1NPC1GAA | |
| SCHEMBL6218966 | 0.68 | PPARD (0.51) | PPARDPPARANR1H4ALDH1A1SMN1; SMN2 | |
| SCHEMBL4856478 | 0.68 | NPC1 (0.53) | PPARDPPARANR1H4ALDH1A1NPC1 | |
| SCHEMBL4856486 | 0.68 | NPC1 (0.53) | PPARDPPARANR1H4ALDH1A1NPC1 | |
| SCHEMBL3371882 | 0.68 | NPC1 (0.53) | PPARDPPARANR1H4ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125753-A1 | FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY | Takeda Pharmaceutical Company Limited (JP) | 2009-12-02 | — | — | EP | claimed |
| WO-2008082003-A1 | FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-07-10 | — | — | WO | claimed |
| EP-2125753-A1 | FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY | Takeda Pharmaceutical Company Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008082003-A1 | FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-07-10 | — | — | WO | disclosed |